Marshall Wace, LLP Axogen, Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Axogen, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 110,354 shares of AXGN stock, worth $1.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

110,354

Holding current value

$1.85 Million

% of portfolio

0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.52 - $14.69 $829,862 - $1.62 Million	110,354 New	110,354 $1.55 Million
Q2 2022 Aug 15, 2022	SELL	$6.99 - $10.0 $425,851 - $609,230	-60,923 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.26 - $10.7 $936,677 - $1.38 Million	-129,019 Reduced 67.93%	60,923 $484,000
Q4 2021 Feb 14, 2022	BUY	$8.8 - $16.0 $1.67 Million - $3.04 Million	189,942 New	189,942 $1.78 Million
Q3 2020 Nov 16, 2020	SELL	$10.62 - $13.12 $927,667 - $1.15 Million	-87,351 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$7.35 - $10.81 $642,029 - $944,264	87,351 New	87,351 $807,000
Q4 2019 Feb 14, 2020	SELL	$11.18 - $18.6 $885,578 - $1.47 Million	-79,211 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$12.09 - $20.46 $923,180 - $1.56 Million	-76,359 Reduced 49.08%	79,211 $989,000
Q2 2019 Aug 14, 2019	SELL	$18.5 - $25.47 $1.33 Million - $1.84 Million	-72,122 Reduced 31.68%	155,570 $3.08 Million
Q1 2019 May 14, 2019	SELL	$14.62 - $22.13 $17.8 Million - $26.9 Million	-1,217,773 Reduced 84.25%	227,692 $4.8 Million
Q4 2018 Feb 14, 2019	BUY	$17.09 - $38.25 $6.24 Million - $14 Million	364,923 Added 33.77%	1,445,465 $29.5 Million
Q3 2018 Nov 14, 2018	SELL	$34.05 - $55.9 $3.01 Million - $4.94 Million	-88,411 Reduced 7.56%	1,080,542 $39.8 Million
Q2 2018 Aug 14, 2018	BUY	$36.15 - $52.5 $42.3 Million - $61.4 Million	1,168,953 New	1,168,953 $58.7 Million

Others Institutions Holding AXGN

# of Institutions

162

Shares Held

36.6M

Call Options Held

230K

Put Options Held

400

First Light Asset Management, LLC Edina, MN

4.09M
Shares

$68.4 Million
5.0% of portfolio
Black Rock Inc. New York, NY

3.25M
Shares

$54.4 Million
0.0% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

3.01M
Shares

$50.3 Million
3.58% of portfolio
Morgan Stanley New York, NY

2.9M
Shares

$48.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.43M
Shares

$40.6 Million
0.0% of portfolio

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $707M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account